Comparison of Clinical Outcomes Following Gefitinib and Erlotinib Treatment in Non–Small-Cell Lung Cancer Patients Harboring an Epidermal Growth Factor Receptor Mutation in Either Exon 19 or 21
2014 ◽
Vol 9
(4)
◽
pp. 506-511
◽
2010 ◽
Vol 137
(4)
◽
pp. 687-694
◽
2003 ◽
Vol 13
(5)
◽
pp. 289-298
◽